Interferon Beta-1a (AVONEX®) as a Treatment Option for Untreated Patients with Multiple Sclerosis (AXIOM): A Prospective, Observational Study.

Autor: Kleinschnitz, Christoph1 christoph.kleinschnitz@uni-wuerzburg.de, Niemczyk, Gabriele2 Gabriele.Niemczyk@biogen.com, Rehberg-Weber, Karin2 karin.rehberg-weber@biogen.com, Wernsdörfer, Colin2 colin.wernsdoerfer@biogen.com
Zdroj: International Journal of Molecular Sciences. Jul2015, Vol. 16 Issue 7, p15271-15286. 16p. 1 Color Photograph, 2 Black and White Photographs, 1 Diagram, 2 Charts, 2 Graphs.
Databáze: Academic Search Ultimate